Healthcare Industry News: Royal Philips
News Release - April 27, 2006
Philips Partners with EDDA Technology to Increase Detection Rate of Lung Lesions with Digital RadiographyAgreement with diagnostic image analysis software developer to enable earlier disease diagnosis
AUSTIN, Texas, April 27 (HSMN NewsFeed) -- At the Society for Computer Applications in Radiology's (SCAR) annual meeting, Royal Philips Electronics (NYSE: PHG; AEX: PHI) today announced that it has entered a strategic partnership with EDDA Technology to provide advanced digital radiography solutions to assist in the detection of lung lesions. Philips has licensed EDDA Technology's IQQA-Chest software, which is designed to help clinicians identify, quantify, evaluate and report pulmonary nodules. The innovative software will be available as part of the Philips digital radiography portfolio, providing an integrated hardware and software solution.
By bridging the gap between the clinician's interpretation based upon patient-specific knowledge and computer analysis of the information captured by the X-ray, IQQA-Chest helps clinicians increase their performance while improving the efficiency for the analysis of each image. In clinical environments, the solution has been shown to increase the discovery rates of small nodules up to over 85 percent in comparison to detection without IQQA assistance, which varies between 35 and 65 percent. The first real-time interactive diagnostic analysis system, IQQA-Chest integrates advanced computer analysis technology into the clinicians' diagnostic process.
"Early diagnosis of diseases such as lung cancer can dramatically improve the clinical outcome for patients," commented Dr. Peter Reimer, global marketing director General X-Ray, Philips Medical Systems. "Through our partnership with EDDA Technology we're providing clinicians with a new set of tools to aid in their detection of lung lesions at an early stage. IQQA-Chest complements our extensive radiography product portfolio and will ultimately lead to greater diagnostic confidence, resulting in better quality of care for patients."
"Our partnership with Philips reflects the increasingly important role that advanced computer assistance plays in the diagnosis of potentially life- threatening diseases," said Dr. Jian-Zhong Qian, president and CEO of EDDA Technology. "By combining IQQA-Chest with the broad Philips digital radiography portfolio clinicians can benefit from a powerful diagnostic solution across a wide range of equipment types. We are pleased about the strategic alliance with Philips and look forward to working closely together in future developments of our innovative solution."
IQQA-Chest will be available in combination with the entire Philips digital radiography portfolio, including DigitalDiagnost, the company's state-of-the-art solution for direct digital radiography. The product will initially be available in the United States and China where the product has received regulatory clearance, and will become available in additional countries from 2007.
A demonstration of IQQA-Chest will be featured at the Philips booth at the SCAR annual meeting, booth number 623.
IQQA is a registered trademark of EDDA Technology, Inc.
For further information please contact:
Tel: +1 425 487 7479
Gert van Santen
Tel: +31 40 27 82682
Timothy D. Ketchmark
Tel: +1 609 915 2504
Tel: +86 (21) 6390 7025
About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG; AEX: PHI) is one of the world's biggest electronics companies and Europe's largest, with sales of $37.7 billion (EUR 30.4 billion) in 2005. With activities in the three interlocking domains of healthcare, lifestyle and technology and 161,498 employees in more than 60 countries, it has market leadership positions in medical diagnostic imaging and patient monitoring, color television sets, electric shavers, lighting and silicon system solutions. News from Philips is located at http://www.philips.com/newscenter.
About EDDA Technology, Inc.
EDDA Technology, Inc. is a clinical computer solution provider in diagnostic imaging and analysis. EDDA offers a series of new generation software products to enable early detection of diseases and to enhance precision in diagnosis and treatment. EDDA's goal is to deliver advanced information analysis technologies that improve clinical workflow and accuracy. A privately held Delaware corporation, EDDA is headquartered in Princeton Junction, New Jersey, and has a subsidiary in Shanghai, China. More information about EDDA is located at http://www.edda-tech.com.
Source: EDDA Technology
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.